Background: Hypotheses on the development of postoperative delirium (PD) include "neuroinflammatory," "neuronal aging," "oxidative stress," "neurotransmitter deficiency," and "neuroendocrine." Here, we employed metabolomics to determine the serum metabolites in the baseline associated with an increased risk of PD. Methods: Two hundred and nine elderly hip-fracture patients who had undergone hemiarthroplasty and had completed our assessments were selected. Fasting venous blood was collected at 7:00 on the morning of surgery and a serum sample bank was created for analysis. On the first 3 postoperative days, the patients were assessed twice daily using the Confusion Assessment Method -Chinese Revision. Ultimately, 43 patients were diagnosed with PD, who comprised the PD group. Meanwhile, 43 matched non-PD patients were selected based on age, sex, and body mass index. Serum samples from the two groups were analyzed by gas chromatography-time-of-flight mass spectrometry and Acquity ultra-performance liquid chromatography-quadrupole time-of-flight mass spectrometry. Results: The demographic characteristics of the groups were matched. Four metabolites associated with an increased risk of PD were identified, including S-methylcysteine, linolenic acid, eicosapentaenoic acid, and linoleic acid. Conclusions: Multiple metabolic pathways in the PD group altered before surgery, including deficiency of ω3 and ω6 fatty acids, energy metabolism and oxidative stress with interactions between hypoxia and mitochondrial dysfunction, in addition to glutamate-glutamine cycle dysfunction. These metabolic abnormalities could possibly increase the fragility of the brain and then contribute to PD.
Postoperative delirium (PD) is a common postoperative complication in elderly patients. Several studies have reported that the incidence of PD in elderly hip-fracture patients is between 20% and 50% (1, 2) . This complication usually occurs during the first 24-48 postoperative hours. It is characterized by acute and fluctuating neurological impairment, including disturbances in attention, memory, orientation, perception, and psychomotor behavior (3) . This condition contributes to the burden of care, prolongs hospitalization time, increases morbidity and mortality during hospitalization, and leads to long-term cognitive impairment or even permanent dementia (4) .
Metabolomics is an efficient technique used to detect perturbations in the metabolome, providing detailed information on the biochemical phenotype of an organism in a healthy or pathophysiologic state (5) . Metabolomics has a powerful ability to reveal the unique chemical fingerprints left behind by cellular processes (6) . Metabolomics platforms can be used to track biochemical alterations that might precede or precipitate pathological changes.
Hypotheses on the development of delirium include "neuroinflammatory," "neuronal aging," "oxidative stress," "neurotransmitter deficiency," "neuroendocrine," "diurnal dysregulation," and "network disconnectivity" (7) . Several studies have demonstrated the risk factors for PD from the perspective of pathophysiology or epidemiology (8, 9) . Elderly patients with preoperative cognitive impairment, dementia, anxiety, depression, and malnutrition are at greater risk of PD (10, 11) . Moreover, a variety of serum biomarkers act as risk factors for delirium (12) . These pathophysiological processes or serum biomarkers (eg, serum chemistries, genetic markers, anticholinergic activity, amino acids, and cortisol) could be reflected through metabolomics. Here, we employed gas chromatographytime-of-flight mass spectrometry (GC-TOFMS) and Acquity ultraperformance liquid chromatography-quadrupole time-of-flight mass spectrometry (Acquity UPLC-QTOFMS) to expand upon the spectrum of detectable serum metabolites. Determining the baseline risk metabolites would probably contribute to early diagnosing PD and understanding the mechanism underlying the development of PD. These results might facilitate the development of strategies for early intervention of these metabolic disturbances to prevent PD.
Methods

Patients and Setting
We selected 209 elderly hip-fracture patients who had undergone hemiarthroplasty and completed our assessments over past several months. The exclusion criteria were as follows: American Society of Anesthesiologists (ASA) physical status of above or equal to III; age of 65 and younger and 80 and older; Mini-Mental State Examination (MMSE) score of less than 24 or dementia due to various etiologies; history of neurological or mental illness; preoperative delirium; current use of tranquilizers or antidepressants; history of an endocrine or metabolic disorder; recent use of glucocorticoids or other hormones; anesthesia duration of more than 3 hours; receipt of secondary surgery or history of severe infectious complications (we used the presence of more than two Systemic Inflammatory Response Syndrome criteria as a marker of inflammation [ACCP/ SCCM]) (13); unwillingness to complete the experimental procedures or the presence of a language barrier; severe hearing or visual impairment; illiteracy; and alcohol or drug dependence. This study was approved by the Ethics Committee of Shanghai Sixth People's Hospital affiliated with Shanghai Jiao Tong University (Shanghai, China) and was registered in the China Clinical Trial Registry (No.: ChiCTR-CPC-15006141). All patients provided written informed consent.
Dietary Management
After admission, all patients were placed on a bland diet and began fasting at 22:00 on the night before surgery. They were started on a semiliquid diet at 6 hours after surgery and were subsequently advanced to a bland normal diet.
Anesthesia and Surgical Management
All patients underwent hemiarthroplasty under the same type of general anesthesia. Systolic blood pressure, diastolic blood pressure, pulse oxygen saturation, electrocardiogram, bispectral index, and end-tidal CO 2 (ETCO2) were continuously monitored during the perioperative period. Anesthesia was induced with intravenous midazolam, sufentanil, propofol, and vecuronium administered in succession and the analgesic and muscle relaxant effects were maintained with sevoflurane inhalation, continuous intravenous infusion of propofol, and intermittent intravenous administration of sufentanil and vecuronium. Intraoperative circulatory system was maintained stability by adjusting the anesthesia depth and administering transfusions or cardiovascular agents as necessary. After surgery, all of the patients were transferred to surgical intensive care unit and received the same treatments.
Blood Sample Collection and Sample Bank Establishment
The general characteristics of the patients included in this study were documented. Fasting venous blood was collected at 7:00 on the morning of surgery. The serum was then separated and stored in a −80°C freezer (SANYO, Japan) for metabolomics analysis. Pooled quality control (QC) samples were prepared by combining 20 μL of each serum sample.
Assessment of PD and Patient Grouping
The MMSE was administered to screen for preoperative cognitive function at 1 day before surgery. The same attending anesthesiologist assessed delirium twice daily (8:00 and 20:00) preoperatively and during the first 3 postoperative days. The Confusion Assessment Method -Chinese Revision (CAM-CR), which derived from the Confusion Assessment Method (CAM) was used to assess delirium (14) . The CAM includes evaluation for the following four characteristics: (i) acute change or fluctuating course of mental status, (ii) inattention, (iii) altered level of consciousness, and (iv) disorganized thinking. A positive finding for a delirium diagnosis requires the presence of items (i) and (ii) and either (iii) or (iv) (15) .
Consort diagram (Figure 1) shows the patient flow in our matched case-control study. Ultimately, 209 patients met our criteria and completed the study. Forty-three patients were diagnosed with PD and constituted the PD group. Meanwhile, 43 matched non-PD patients were selected based on age, sex, and body mass index. 
Serum Sample Preparation and GC-TOFMS Analysis
According to our previously published protocol (16) , a 100 μL aliquot of each serum sample was spiked with two internal standards. When the sample preparation was completed, the samples were placed at room temperature for 1 hour prior to GC-TOFMS analysis (Pegasus HT, Leco, St. Joseph, MI; electron ionization mode), which was performed in the order of "PD and Non-PD." One QC sample and one blank vial were run after every 10 serum samples. A 1-μL injection volume was used in the splitless mode. A DB-5 ms capillary column (30 m × 250 μm i.d., 0.25-μm film thickness; 5% diphenyl cross-linked 95% dimethylpolysiloxane) was used for the separation of metabolites. Helium (99.9996%) was used as the carrier gas, with a continuous flow rate of 1 mL/min. The GC oven temperature was started at 80°C for 2 minutes and it was then increased to 180°C at 10°C/ min, to 230°C at 6°C/min, and lastly, to 295°C at 40°C/min, at which it was maintained for 8 minutes. The temperatures for injection, the transfer interface, and the ion source were set to 270, 260, and 220°C, respectively. The mass range was set to 30-600 with electron impact ionization (70 eV) and the acquisition rate was 20 spectra/s. The files obtained from GC-TOFMS analysis were exported in NetCDF format using ChromaTOF software (v4.44, Leco, Los Angeles, CA). CDF (common data format) files were pretreated by performing baseline correction, denoising, smoothing, alignment, time-window splitting, and multivariate curve resolution, based on the recommendations of a kit developed by MATLAB 7.0 (MathWorks, Natick, MA), R 10.2 (Lucent Technologies) and JavaSE 1.6 (Sun Microsystems). The internal standard and QC samples were used for QC analysis of reproducibility and the QC data were used for normalization. Ion peaks generated by the internal standard were also removed.
Serum Sample Preparation and UPLC-QTOFMS Analysis
Two 40-μL aliquots of each serum sample were obtained for use in UPLC-QTOFMS electrospray (ES)− and ES+ analyses, respectively. Samples were prepared for QC analysis using a procedure similar to that used to prepare samples for GC-TOFMS analysis. The sampling sequence was the same as that used in GC analysis and the samples were kept at 4°C throughout the entire procedure. The UPLC-QTOFMS ES+ and ES− raw data were analyzed using MarkerLynx Applications Manager version 4.1 (Waters, Manchester, UK) with the following parameters: an initial time and final retention time (RT) of 0 and 9.5 minutes, respectively. The mass range was set to 50-1,000 Da, with a mass window of 0.05 Da. The internal standard detection parameters were deselected for peak RT alignment. The isotopic peaks were excluded from analysis. The minimum intensity was set to 5% of the base peak intensity. The noise elimination level was set to 6 and RT tolerance was set to 0.3 minutes. A list of the ion intensities of each peak detected was generated using the RT and m/z data pairs as the identifier for each ion. The resulting three-dimensional matrix contained an arbitrarily assigned peak index (RT−m/z pairs), sample names (observations), and ion intensity information (variables). To obtain consistent differential variables, the resulting matrix was further reduced by removing any peaks with a missing value (ion intensity = 0) in more than 80% of the samples. The internal standard and QC data were used for QC analysis of reproducibility and the QC data were used for normalization. Ion peaks generated by the internal standard were also removed.
Identification of Metabolic Profiles
By GC-TOFMS analysis, 120 metabolites were annotated by comparing mass fragments and RTs with NIST 05 standard mass spectral databases and our laboratory standard libraries (which cover >800 metabolites and are still expanding). By UPLC-QTOFMS analysis, 142 metabolites were annotated by comparing the accurate mass (m/z) and RT with reference standards and available web-based resources, such as the Human Metabolome Database (www.hmdb. ca). Ultimately, a total of 214 metabolites were identified through GC-TOFMS and UPLC-QTOFMS after removing the reduplicate compounds. Among the all metabolites, 40 were fatty acids, 39 were amino acids, 16 were carbohydrates, and others were organic compounds (such as cholic acid, organic acid, and amine). A principal components analysis score plot constructed based on the serum samples collected from patients in the PD and Non-PD groups did not show separate clusters for these two groups. Partial least squares discriminant analysis (PLS-DA) and orthogonal partial least squares discriminant analysis (OPLS-DA) models were implemented to visualize the metabolic differences between the PD and Non-PD groups. The R2X, R2Y, and Q2Y values of the OPLS models in the PD versus Non-PD groups were nearly 1.0, indicating that these models were able to explain and predict variations in the X and Y matrices. Significantly altered metabolites with variable importance in the projection values (variable importance in the projection > 1) in the abovementioned OPLS-DA model, as well as differing p values determined by Student's t test (p < .05), were selected in the two groups. Furthermore, the Kyoto Encyclopedia of Genes and Genomes (KEGG) database was used to identify the pathways associated with the altered metabolites. Details of the cross-validation of the constructed principal components analysis and OPLS models and the raw metabolic data are available via the free website http:// pubs.acs.org.
Statistical Analysis
Statistical data analysis was performed using SPSS (SPSS, Chicago, IL) and SIMCA-P 12.0.1+ (Umetrics, Umea, Sweden). Since the two groups were strictly matched with age, sex, and body mass index, although the two groups were different individuals, we used paired-samples t test to do the comparisons between the different study groups. For non-normally distributed data, the Kolmogorov− Smirnov (K−S) test and the Mann−Whitney−Wilcoxon test was performed. The permutation test was conducted to validate the OPLS models. The chi-square test or Fisher's exact test was used to compare qualitative data. A p less than .05 was considered significant.
Given the success of the OPLS models in classifying the PD and Non-PD groups, a total of 31 differentially expressed metabolites were identified. Then, Bonferroni adjustment and logistic regression were conducted to identify the risk factors for delirium. In logistic analysis, since the two groups were strictly matched with age, sex, and body mass index, these parameters were not included in the covariates. Moreover, we used Bonferroni adjustment for the analysis to minimize false-positive rate. The sample size was calculated using the number of risk factors for PD. The sample size was equal to 5 to 10 times the number of variables according to an empirical formula of sample size estimation. Therefore, 209 patients completed our observation and 43 patients developed PD who met this sample size criterion.
Results
Comparison of General Characteristics Between PD and Non-PD Groups
The patients' demographic data are shown in Table 1 . The incidence of PD in the elderly hip-fracture patients who had undergone hemiarthroplasty was 20.6% (43/209). There were no significant differences in age, gender, body mass index, education level, ASA grade, preoperative MMSE score, preoperative Charlson's Comorbidity Index, or other general characteristics between the PD and Non-PD groups (p > .05).
Metabolic Profiles of PD and Non-PD Groups Before Surgery
Typical GC-TOFMS and UPLC-QTOFMS total ion current chromatograms of a patient's serum are shown in Figure 2 . The resulting spectrum was analyzed with H-MCR toolbox in Matlab and SIMCA-p software.
Given the success of the principal components analysis and OPLS models in classifying the PD and Non-PD groups (Figure 3 ), a total of 31 differentially expressed metabolites were identified (Tables 2  and 3 ). Of these metabolites, the levels of 11 fatty acids (eg, linolenic acid, eicosapentaenoic acid, and docosahexaenoic acid) were significantly decreased, including unsaturated and saturated fatty acids. Besides, the plasma levels of mannose, fumaric acid, 2-hydroxybutanoic acid, 3-hydroxybutyric acid, ribose, 3-phenylbutanoic acid, phenylalanine, and cystine were increased in the PD group compared with the Non-PD group, while S-methylcysteine, α-alanine, 1,5-anhydro-D-sorbitol, uric acid, taurine, citric acid, cholesterol, tocopherol, uracil, malonic acid, cysteine, and glutamine (Gln) level were markedly decreased. In addition to fatty acid metabolism, the tricarboxylic acid cycle, carbohydrate metabolism, nucleic acid metabolism, and glutamate-glutamine (Glu-Gln) cycle were also altered in the PD group before surgery.
Potential Metabolites Associated With Increased Risk of PD
To identify the metabolites associated with an increased risk of PD, logistic regression analyses were performed to determine the most qualified metabolic candidates after Bonferroni adjustment. Ultimately, 31 metabolites were found to be associated with PD with these four highest significant levels (Tables 2 and 3 ). Using the Akaike information criterion, a measurement with a trade-off between the complexity and goodness-of-fit of the model, the logistic regression model with four variables was found to explain most of the deviations between the PD and Non-PD groups with the smallest values. The four corresponding metabolites were S-methylcysteine, linolenic acid, eicosapentaenoic acid, and linoleic acid (Tables 2 and  3 ). Figure 3 indicated equivalent diagnoses compared with those obtained from the clinical interviews. Meanwhile, after retrieved KEGG database, the different metabolites suggested that multiple metabolic pathways were altered in the PD group before surgery, including deficiency of ω3 and ω6 fatty acids, energy metabolism and oxidative stress with interactions between hypoxia and mitochondrial dysfunction, as well as disorders in Glu-Gln cycle (Figure 4) .
Discussion
Hypotheses about PD development include "neuroinflammatory," "neuronal aging," "oxidative stress," "neurotransmitter deficiency," "neuroendocrine," "diurnal dysregulation," and "network disconnectivity" (7) . Studies have found that preoperative cognitive impairment, dementia, anxiety, depression, and nutrition deprivation are associated with PD (10,11). Vasunilashorn and colleagues found that in an older patient population undergoing major elective surgery, several cytokines (particularly IL-6 and IL-2) were involved in the delirium syndrome (17) . Additionally, serum chemistries and genetic markers (eg, Apo E4 or dopamine transporter gene) may act as risk markers (12) . Our metabolomics results suggested that deficiency of ω3 and ω6 fatty acids, energy metabolism and oxidative stress with interactions between hypoxia and mitochondrial dysfunction, as well as disorders in Glu-Gln cycle in the baseline may contribute to the risk of PD. The current findings not only fitted into the previous pathophysiological models of delirium including "neuroinflammatory," "neuronal aging," "neuroendocrine," "oxidative stress, " and "neurotransmitter deficiency" but also extended them ( Figure 4) . Additionally, lack of multiple fatty acids might be the important potential risk for PD. As the majority of these 31 differentially expressed metabolites between the two groups are fatty acids, fatty acid metabolic disturbances might be the primary contributors to PD development. In addition to the levels of unsaturated fatty acids (n-3, n-6 polyunsaturated fatty acids [PUFAs] and monounsaturated fatty acids), those of saturated fatty acids (octadecanoic acid) were significantly decreased in the PD group before surgery.
Fatty acids could influence neurologic function by changing the physiological properties of cell membranes (18) . PUFAs play pivotal roles in neurological and psychological functions (19) . Disturbances in PUFA metabolism have been reported to be involved in neuropsychological diseases, such as major depression, bipolar disorder, schizophrenia, attention deficit hyperactivity disorder, and Alzheimer's disease (AD) (20, 21) .
n-3 PUFAs are essential for neurogenesis, synaptogenesis, and neuroplasticity but they cannot be synthesized in the human body (22, 23) . In particular, eicosapentaenoic acid, α-linolenic acid, and docosahexaenoic acid of the PUFA family mainly aggregate in the cerebrum (23) . A double-blind, randomized, and placebocontrolled trial has indicated that long-chain ω-3 PUFAs may reduce the risk of progression to a psychotic disorder for young people with a subthreshold psychotic state (24) . Higher dietary intake of ω-3 PUFA is related to a lower plasma β-amyloid 42 (Aβ42) level, a profile associated with decreased risk of incident AD and the slowing of cognitive decline in a previously studied cohort (25) . On the other hand, ω-6 PUFAs (eg, arachidonic acid) regulate neuroinflammation. Evidence shows that an increase in the arachidonic acid level is actually associated with reductions in the proinflammatory IL-6 and IL-1 levels and an increase in the anti-inflammatory tumor necrosis factor-β level (26) . Arachidonic acid and its metabolites have also been suggested to be involved in the production of β-amyloid and in the pathogenesis of AD (27) . Thus, the decreases in both the plasma ω-3 and ω-6 PUFA levels in the PD group before surgery indicate the existence of deficiencies in neuroprotective elements against the responses to excessive stress and inflammation induced by surgery.
Hypoxia promotes the pathogenesis of AD by accelerating tau hyperphosphorylation, boosting Aβ accumulation, impairing the normal function of the blood-brain barrier, and promoting neuron degeneration (28) . Here, our data revealed that the levels of intermediate products of the tricarboxylic acid cycle, such as citric acid, were significantly lower in the PD group compared with the Non-PD group. In contrast, the levels of products of glycolysis (the main pathway of carbohydrate metabolism), including mannose and ribose, were higher in the PD group compared with the Non-PD group. We suggest that sustained systemic hypoxia was present in the PD group. If the tricarboxylic acid cycle cannot produce enough adenosine triphosphate (ATP) because of hypoxia or an insufficient oxygen supply, then glycolysis can be promoted to compensate for this deficiency. However, extended hypoxia ultimately exacerbates hypoxic events, including stimulation of mitochondrial complex III to generate large amounts of reactive oxygen species (29) . Furthermore, disturbances in nucleic acid metabolism have been observed in the pathogenesis of AD (30) . As our results show, the levels of several metabolites involved in the pyrimidine and purine metabolic pathways were altered in the serum samples from patients in the PD group compared with those from patients in the Non-PD group, which partially reflected the enhanced oxidative damage to the cell nucleus and mitochondrial DNA.
Glutamate (Glu) is widely recognized as the primary excitatory neurotransmitter in the brain and it plays crucial roles in cognitive function and in the development of neurodegenerative disorders. Glu released from neurons is taken up by astrocytes and reconverted to Gln, completing the so-called "Glu-Gln" cycle. This cycle between neurons and astrocytes demands that a sufficient supply of the neurotransmitter glutamic acid is preserved in the central nervous system (31) . We found a marked decrease in the Gln level in the serum samples from the patients in the PD group, indicating that the Glu-Gln cycle might be yielded with the decreased Glu activity in the PD group. Second, because cystine is transferred into cells in exchange for Glu, the depressed Glu activity might result in the transfer of less cystine into cells (32) . This finding may help to explain the increasing trend in the serum cystine level observed in the PD group. Third, as taurine is the biochemical precursor of Gln, the marked decrease in the taurine level could have potentially contributed to the Gln level in the PD group. Additionally, a disturbance in Glu-Gln homeostasis might give rise to cognitive impairment in the elderly adults (33) .
In conclusion, we revealed the presence of alterations in multiple metabolic pathways in the PD group before surgery, including deficiency of ω3 and ω6 fatty acids, energy metabolism and oxidative stress with interactions between hypoxia and mitochondrial dysfunction, as well as disorders of the Glu-Gln cycle (Figure 4 ). These metabolic abnormalities could possibly increase the fragility of the brain and then lead to PD.
Limitations
Metabolomics analysis is a way to suggest metabolic differences between populations of patients and may reveal associations between metabolic profiles and a disease. Here, we employed metabolomics platforms to find risk serum metabolites in the baseline for PD. The purpose of this study was to find potential preoperative serum metabolites in normal people who were more easily to have delirium after operation. We did not collect the postoperative samples. Our understandings of these altered metabolic pathways and their underlying mechanisms seem a bit premature. The exact mechanism between these metabolic disturbances and PD need to be validated subsequently. Moreover, for the convenience of metabolomics analysis and reduction of confounding factors, we carried out this case-control study with strict exclusion criteria. These restrictions may limit the generalizability of these findings to more diverse patient groups. Table 2 suggested that multiple metabolic pathways were altered in the PD group before surgery (compared with Non-PD group). For instance, (i) In fatty acid metabolic pathway, a variety of fatty acids were decreasing which including ω3 and ω6 fatty acids. (ii) The reduced levels of cysteine and citric acid and increased fumaric acid reflected the energy metabolism and oxidative stress with interactions between hypoxia and mitochondrial dysfunction. (iii) The lessened taurine and glutamine implied the disorders in glutamateglutamine cycle and other neurotransmitter systems (eg, dopamine, serotonin). (iv) The increased creatinine and decreased uric acid in the elderly hip-fracture patients prompted malnutrition or decreased hepatic and renal function. ALA = α-linolenic acid; DHA = docosahexaenoic acid; EPA = eicosapentaenoic acid.
